LMFA Q1 2026 Earnings EPS Misses Estimates as Challenges Persist Calidi Biotherapeutics Q4 2025 Earnings Narrowed Loss Surprises Stock Declines BNS Q1 2026 Earnings EPS Surpasses Estimates Amid Strong Operating Performance TELA Bio Q1 2026 Earnings EPS Misses Estimates Amid Stock Rally BNR Q3 2022 Earnings NarrowerThanExpected Loss Fails to Lift Stock FONR Q1 2025 Earnings Profitability Maintained Amid Limited Disclosure